Status:
COMPLETED
Physical Activity in Haemodialysis Patients: a Feasibility Study
Lead Sponsor:
Oxford Brookes University
Collaborating Sponsors:
Oxford University Hospitals NHS Trust
Conditions:
End Stage Renal Failure on Dialysis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
There is a well established link between physical inactivity and increased mortality in the general population and across many of the more common disease areas including chronic kidney disease (CKD). ...
Detailed Description
There is a well established link between physical inactivity and increased mortality in the general population and patients with chronic kidney disease (CKD) have low fitness levels when compared to t...
Eligibility Criteria
Inclusion
- • Participant is willing and able to give informed consent for participation in the trial.
- Male or Female, aged 18 years or above.
- Undergoing regular haemodialysis (2 or 3 times per week) in the Oxford Main and Tarver Dialysis Units
- Is able and willing to comply with all trial requirements.
- Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the trial.
Exclusion
- Unable to give consent
- Poor dialysis compliance
- Female participant who is pregnant, lactating or planning pregnancy during the course of the trial.
- Participant with life expectancy of less than 1 month and/or receiving palliative care.
- Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial.
- Planning to leave Oxford Dialysis units within the study trial
- Absolute contra-indications to PA including:
- Recent significant change in resting ECG suggesting significant ischaemia, recent Myocardial Infarction within 2 days or acute cardiac event
- Unstable angina
- Uncontrolled cardiac arrhythmia causing symptoms or haemodynamic compromise
- Symptomatic severe aortic stenosis
- Uncontrolled symptomatic heart failure
- Acute pulmonary embolus or infarction
- Acute myocarditis or pericarditis
- Third degree heart block
- Suspected or know dissecting aortic aneurysm
- Acute systemic infection, accompanied by fever, body aches or swollen lymph glands
Key Trial Info
Start Date :
September 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 29 2020
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT04103177
Start Date
September 23 2019
End Date
May 29 2020
Last Update
April 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oxford University Hospitals NHS FT
Oxford, Oxfordshire, United Kingdom, OX3 7LE